Parabilis Medicines, Inc. (NASDAQ:PBLS – Get Free Report) Director Alan Sebulsky purchased 9,065 shares of the firm’s stock in a transaction that occurred on Monday, June 15th. The shares were acquired at an average price of $26.49 per share, for a total transaction of $240,131.85. Following the completion of the transaction, the director owned 30,000 shares in the company, valued at $794,700. The trade was a 43.30% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink.
Alan Sebulsky also recently made the following trade(s):
- On Friday, June 12th, Alan Sebulsky purchased 8,435 shares of Parabilis Medicines stock. The shares were acquired at an average price of $27.67 per share, for a total transaction of $233,396.45.
- On Thursday, June 11th, Alan Sebulsky purchased 12,500 shares of Parabilis Medicines stock. The shares were acquired at an average price of $20.00 per share, for a total transaction of $250,000.00.
Parabilis Medicines Stock Performance
NASDAQ PBLS traded up $1.58 during trading hours on Tuesday, reaching $26.59. 3,379,657 shares of the company’s stock were exchanged, compared to its average volume of 1,824,139. Parabilis Medicines, Inc. has a one year low of $24.51 and a one year high of $34.47.
See Also
- Five stocks we like better than Parabilis Medicines
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Receive News & Ratings for Parabilis Medicines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Parabilis Medicines and related companies with MarketBeat.com's FREE daily email newsletter.
